Science Explorer Interactive view Map
Hospital / health system · Montpellier · France

Institut Regional du Cancer de Montpellier

Research works
91
▼ 40% vs 2013–17
Citations
2k
22.3 per fractional work
Top-10% rate
17.0%
record average 16.5%
Open access
54%
world 28%

Not ranked overall: Institut Regional du Cancer de Montpellier is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.15× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.86× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 1.87× its world share, 0 worksImmunology and Micro…Neuroscience: 0.12× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.94× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.16× its world share, 0 worksChemistryComputer Science: 0.12× its world share, 0 worksComputer ScienceEngineering: 0.03× its world share, 0 worksEngineeringEnvironmental Science: 0.15× its world share, 0 worksEnvironmental ScienceMathematics: 0.54× its world share, 0 worksMathematicsPhysics and Astronomy: 0.77× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.47× its world share, 0 worksHealth ProfessionsMedicine: 3.28× its world share, 12 worksMedicineNursing: 0.40× its world share, 0 worksNursingDecision Sciences: 0.15× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.15× its world share, 0 worksEconomics, Econometr…Psychology: 0.08× its world share, 0 worksPsychologySocial Sciences: 0.08× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.9×. Every wedge is a field page.

Which keywords describe research at Institut Regional du Cancer de Montpellier?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Targeted Therapy, Neoadjuvant Therapy, Clinical Practice Guidelines, Radiotherapy, Clinical Trials and Breast Cancer.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy13▲ 20×21 topics
  2. Immunotherapy7▲ 12×15 topics
  3. Targeted Therapy7▲ 34×5 topics
  4. Clinical Practice Guidelines6▲ 12×10 topics
  5. Neoadjuvant Therapy6▲ 30×5 topics
  6. Quality of Life6▲ 4.8×16 topics
  7. Radiotherapy5▲ 16×12 topics
  8. Cancer5▲ 4.1×25 topics
  9. Breast Cancer5▲ 19×9 topics
  10. Clinical Trials5▲ 8.7×11 topics
  11. Dosimetry5▲ 55×2 topics
  12. Survival Analysis5▲ 19×7 topics
  13. Tumor Microenvironment4▲ 14×7 topics
  14. Metastasis4▲ 14×10 topics
  15. Biomarkers4▲ 7.3×10 topics
  16. Molecular Subtypes4▲ 51×2 topics
  17. Precision Medicine3▲ 12×5 topics
  18. Prognostic Factors3▲ 7.9×14 topics
  19. Cancer Treatment3▲ 12×5 topics
  20. Cetuximab3▲ 39×2 topics
  21. Genomic Instability3▲ 25×3 topics
  22. PET Imaging3▲ 15×4 topics
  23. Adjuvant Chemotherapy3▲ 42×2 topics
  24. Gene Expression3▲ 5.1×9 topics
  25. BRAF Mutation3▲ 41×2 topics
  26. Cancer Risk3▲ 11×6 topics
  27. Metastatic Breast Cancer3▲ 43×2 topics
  28. Cytoreductive Surgery2▲ 43×2 topics
  29. Tumor Markers2▲ 39×2 topics
  30. Cancer Genomics2▲ 48×1 topic
  31. Cell-Free DNA2▲ 29×2 topics
  32. Image-Guided Radiotherapy2▲ 51×1 topic
  33. Molecular Characterization2▲ 14×5 topics
  34. Mutational Signatures2▲ 48×1 topic
  35. Radiotherapy Physics2▲ 51×1 topic
  36. Ovarian Cancer2▲ 28×2 topics
  37. Prognostic Markers2▲ 27×3 topics
  38. Radioimmunotherapy2▲ 60×1 topic
  39. Radiopharmaceuticals2▲ 60×1 topic
  40. Fluorouracil2▲ 71×1 topic

Which research topics does Institut Regional du Cancer de Montpellier publish most on?

By volume in 2022–2025: Radiopharmaceutical Chemistry and Applications, Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy and Cancer Immunotherapy and Biomarkers.

  1. 1 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 Ovarian cancer diagnosis and treatment Reproductive Medicine 1 works
  3. 3 PARP inhibition in cancer therapy Oncology 1 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
  5. 5 Cancer Genomics and Diagnostics Cancer Research 0 works
  6. 6 Thyroid Cancer Diagnosis and Treatment Endocrinology, Diabetes and Metabolism 0 works
  7. 7 Lung Cancer Research Studies Oncology 0 works
  8. 8 Colorectal and Anal Carcinomas Surgery 0 works
  9. 9 Cancer Cells and Metastasis Oncology 0 works
  10. 10 Neuroendocrine Tumor Research Advances Epidemiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.9%not open46.1%

World: 28% of research is openly available.

with international co-authors27.3%domestic only72.7%

World: 19% is written across borders.

How has Institut Regional du Cancer de Montpellier's research output changed?

Output in 2018–2022 was 40% lower than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Montpellier

All research institutions in Montpellier

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.